4//SEC Filing
EISENBERG JEFFREY F 4
Accession 0001415889-18-000120
CIK 0001109196other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 7:13 PM ET
Size
7.7 KB
Accession
0001415889-18-000120
Insider Transaction Report
Form 4
EISENBERG JEFFREY F
Director
Transactions
- Sale
Common Stock
2018-01-23$0.87/sh−17,444$15,176→ 82,556 total - Sale
Common Stock
2018-01-24$0.84/sh−17,998$15,118→ 64,558 total
Footnotes (3)
- [F1]Represents a portion of the number of shares required to be sold by the reporting person to cover estimated tax obligations in connection with the vesting of the RSUs of the reporting person. This sale is mandated by the Issuer's election, as approved by the Board of Directors, under the equity incentive plan to require satisfaction of estimated tax obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.89 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.86 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeother
Related Parties
1- filerCIK 0001224096
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 7:13 PM ET
- Size
- 7.7 KB